Global Intermittent Catheters Industry: Key Statistics and Insights in 2025-2033
Summary:
- The global intermittent catheters market size reached USD 2.9 Billion in 2024.
- The market is expected to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.
- North America leads the market, accounting for the largest intermittent catheters market share.
- Urinary incontinence holds the biggest market share on account of the increasing awareness among individuals about urine incontinence.
- Female length catheter accounts for the largest market share due to the rising need to lower the risk of injury or pain.
- The increasing prevalence of urinary disorders, such as urinary incontinence, neurogenic bladder, and benign prostatic hyperplasia (BPH), among the masses around the world is catalyzing the demand for intermittent catheters.
- Innovations in catheter technology are leading to the creation of hydrophilic-coated and antimicrobial catheters that offer enhanced patient comfort and lower infection rates.
Request for a sample copy of this report: https://www.imarcgroup.com/intermittent-catheters-market/requestsample
Industry Trends and Drivers:
- Growing Prevalence of Urinary Disorders:
Fractility, stress urinary incontinence, neurogenic bladder, benign prostatic hyperplasia and other urinary disorders getting prevalent with aging population are driving the growth for intermittent catheters globally among the masses. Since these aforementioned conditions affect normal functioning of the bladder, the patients have to be catheterized frequently in order to control for the urinary output. The increasing prevalence of these disorders in rising population of the global population, particularly the geriatric population, as well as patients with spinal cord injuries or neurological disorders, is fuelling the market growth. Further, due to poor dietary habits, obesity complicating sedentary lifestyles are also increasing the uptake of intermittent catheters as an inevitable tool of management.
- Technological Advancements and Product Innovations:
Recent advancements in the field of catheterization are giving birth to hydrophilic coated and antimicrobial catheters hoping to improve stability and decrease infection rates for catheterized patients. These advancements respond to some of the most important issues of the users, including pain during the insertion of the device as well as the danger of Contracted Unasymmetrical Vaginal Ireversible Little Economy (CUVILE). Alto, self-lubricated as well as disposable catheters also in the aspect of pre-lubricated make the process easier for patients. Every day, some innovate products are being developed that offer better ways of using the available technologies in an effort to enhance safety and thus their usage by patients and other members of health care team is enhanced.
- Increasing Awareness and Adoption in Home Care:
The increasing consciousness by the people of the effectiveness of the intermittent catheter than indwelling ones are fostering the market expansion. The use of Intermittency catheters is receiving the support of key health care professionals and organizations because it is safer and more convenient than the constant use of Foley catheters. Apart from this, the increasing demand for home-based care products, high costs of healthcare treatments are also fueling the market growth rate. Easing of restrictions towards home-based care and self-monitoring especially amongst a aging population is driving the market. Consumers are demanding comfortable and effective products for urinary needs which can be used without assistance.
We explore the factors driving the growth of the market, including technological advancements, consumer behaviors, and regulatory changes, along with emerging intermittent catheters market trends.
Intermittent Catheters Market Report Segmentation:
By Product:
- Uncoated Intermittent Catheter
- Coated Intermittent Catheter
- Antimicrobial
- Hydrophilic
- Others
Uncoated intermittent represents the largest segment as it enhances patient comfort and infection control.
By Indication:
- Urinary Incontinence
- Surgery (Major Surgery)
- Spinal Cord Injury
- Others
Urinary incontinence holds the biggest market share on account of the increasing awareness among individuals about urine incontinence.
By Category:
- Male Length Catheter
- Kids Length Catheter
- Female Length Catheter
Female length catheter accounts for the largest market share due to the rising need to lower the risk of injury or pain.
By End User:
- Hospitals
- Medical Research Centers
- Ambulatory Surgical Centers
Hospitals exhibit a clear dominance in the market, driven by their ability to handle a higher volume of patients.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the intermittent catheters market, which can be attributed to the high prevalence of urological disorders.
Top Intermittent Catheters Leaders:
The intermittent catheters market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Coloplast A/S
- Cure Medical LLC (Convatec Group plc)
- Hollister Incorporated
- Hunter Urology
- Medical Technologies of Georgia Inc.
- Pennine Healthcare Ltd.
- Teleflex Inc
- Wellspect Limited (Dentsply Sirona).
Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145